A Deeper Understanding of Eye Diseases. A New Generation of Medicines.
Character Bio is a clinical-stage biotechnology company developing new medicines for eye diseases, starting with age-related macular degeneration (AMD).
AMD impacts one in eight people over the age of fifty and is a leading cause of blindness globally.
Our mission is clear: Leverage human genetics to understand what drives disease progression so we can discover and develop targeted therapies to protect vision.
THE CHALLENGE
Understanding the Variability of Eye Diseases
Patients who have eye diseases like AMD and glaucoma exhibit different disease manifestations and progress at different rates due to their unique genetic and clinical profiles — but today's therapies often take a one-size-fits-all approach that fails to address underlying disease variability.
At Character Bio, we're leveraging proprietary longitudinal databases to characterize patient subtypes and discover genetic drivers of disease progression for more precise drug targeting.
A New Vision for How Eye Diseases Are Treated
We’ve built Character Arc™, the most advanced disease intelligence system in ophthalmology. Through Character Arc, we bring together longitudinal clinical information, retinal imaging, genetics and other biological data from thousands of patients to understand eye disease across the full arc of a patient’s journey. We also integrate AI-enabled biomarker quantification, generating critical evidence for biological pathway and drug target prioritization.
From Disease Intelligence to Drug Development
The disease intelligence we generate through Character Arc™ informs the opportunities we pursue and how our therapeutics are developed, including drug discovery, clinical trials, and outcomes research.
Latest NEWS
News ·
May 7, 2026
Character Bio at ARVO 2026
The Character Bio team presented three abstracts at the ARVO 2026 conference in Denver
News ·
September 23, 2025
Character Biosciences named a “Fierce 15” Biotech Company of 2025
Character Biosciences featured in Fierce Biotech
Partner With Us
Provider Partnerships
Partner with Character Bio on leading-edge ophthalmology research. Each collaboration is tailored to your practice flow to ensure seamless integration of important research activities while benefiting patients with unmet need.
Patient Research Opportunities
As a patient, you have an opportunity to contribute to research that could deliver better treatments for you and others like you in the future.
Industry Partnerships
Work with us to harness the power of integrated patient data, genomics and machine learning to develop transformative medicines in ophthalmology.